FDA Inspection 1157218 — Stira Pharmaceuticals LLC

Stira Pharmaceuticals LLC — FEI 3017224277

The FDA completed an inspection of Stira Pharmaceuticals LLC on Nov 5, 2021 in Fairfield, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 5, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fairfield, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.